Ifinatamab Biosimilar, N297A Mutant, Endotoxin 0.05 EU/mg | C106P.NA.05
Ifinatamab Biosimilar, N297A Mutant, Endotoxin 0.05 EU/mg. The research grade Pembrolizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should...